Provided herein are novel solid forms of each of four compounds: (1) heptadecan-9-yl 8-((2-hydroxyethyl)amino)octanoate ("Compound 1"), (2) heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoate ("Compound 2"),(3) heptadecan-9-yl 8-((2-hydroxyethyl)(8-(nonyloxy)-8-oxooctyl)amino)octanoate ("Compound 3"), and (6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate ("MC3"), and related compositions and methods.
本文介绍了四种化合物的新型固态形式:(1) 庚
十七烷-9-基8-((2-羟乙基)
氨基)
辛酸酯(“化合物1”),(2) 庚
十七烷-9-基8-((2-羟乙基)(6-氧代-6-(
十一烷氧基)己基)
氨基)
辛酸酯(“化合物2”),(3) 庚
十七烷-9-基8-((2-羟乙基)(8-(壬氧基)-8-氧代辛基)
氨基)
辛酸酯(“化合物3”),以及(6Z,9Z,28Z,31Z)-庚三十七碳六烯-6,9,28,31-四烯-19-基4-(
二甲氨基)
丁酸酯(“MC3”)及其相关组合物和方法。